methylprednisolone has been researched along with CACH Syndrome in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, HR; Dakakni, T; Timmermans, VM | 1 |
| Keceli, AM; Kocaoglu, C; Simsek, N; Yildirim, M | 1 |
| Di Luca, DG; Gultekin, SH; Landman, J; Ortega, MR; Sun, X | 1 |
| Abdilla, Y; Cauchi, M; Vella, N | 1 |
| Goda, F; Otaka, Y; Sakurai, Y; Sato, M; Soma, H; Watanabe, T | 1 |
| Malhotra, A; Needham, M; Reyneke, E | 1 |
| Breiner, A; Casaubon, LK; MacLellan, A; Tang-Wai, DF | 1 |
| Chattopadhyay, P; Dhua, D; Philips, C | 1 |
| Iwanaga, T; Kaneko, N; Kimura, K; Nishimura, H | 1 |
9 other study(ies) available for methylprednisolone and CACH Syndrome
| Article | Year |
|---|---|
Acute Disseminated Encephalomyelitis After SARS-CoV-2 Vaccination.
Topics: COVID-19; COVID-19 Vaccines; Encephalomyelitis, Acute Disseminated; Female; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Leukoencephalopathies; Methylprednisolone; Middle Aged; Neuroprotective Agents; SARS-CoV-2; Tachypnea; Vaccination | 2022 |
Fulminant acute hemorrhagic leukoencephalopathy: ineffective treatment with immunotherapy.
Topics: Encephalomyelitis, Acute Disseminated; Humans; Immunotherapy; Leukoencephalopathies; Magnetic Resonance Imaging; Methylprednisolone; Plasmapheresis | 2022 |
Clinical Reasoning: A 47-year-old man with diffuse white matter disease and rapidly progressive dementia.
Topics: Autoantibodies; Autoimmune Diseases of the Nervous System; Calcium Channels; Dementia; Disease Progression; Glucocorticoids; Humans; Leukoencephalopathies; Male; Methylprednisolone; Middle Aged | 2019 |
Cocaine-induced toxic leucoencephalopathy with complete clinical recovery.
Topics: Cocaine; Confusion; Electroencephalography; Humans; Immunoglobulins; Immunologic Factors; Leukoencephalopathies; Magnetic Resonance Imaging; Male; Mental Disorders; Methylprednisolone; Middle Aged; Plasmapheresis; Substance-Related Disorders; Treatment Outcome; White Matter | 2019 |
[Case report: a case of Epstein-Barr virus associated hemophagocytic syndrome with reversible leukoencephalopathy in the splenium of the corpus callosum].
Topics: Corpus Callosum; Cyclosporine; Dexamethasone; Epstein-Barr Virus Infections; Etoposide; Female; Humans; Leukoencephalopathies; Lymphohistiocytosis, Hemophagocytic; Methylprednisolone; Young Adult | 2013 |
Susac's syndrome: an immune mediated endotheliopathy laden with challenges and controversies.
Topics: Adult; Audiometry, Pure-Tone; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Fluorescein Angiography; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Leukoencephalopathies; Methylprednisolone; Multiple Sclerosis; Susac Syndrome | 2013 |
Clinical Reasoning: A case of subacute cognitive decline in a 76-year-old man.
Topics: Aged; Cerebral Amyloid Angiopathy; Cognition Disorders; Humans; Leukoencephalopathies; Male; Methylprednisolone; Neuroprotective Agents | 2016 |
Reversible diffuse neurological deficits in systemic lupus erythematosus: report of a case.
Topics: Brain; Female; Humans; Infusions, Intravenous; Leukoencephalopathies; Lupus Erythematosus, Systemic; Lupus Vasculitis, Central Nervous System; Magnetic Resonance Imaging; Methylprednisolone; Nervous System Diseases; Young Adult | 2011 |
[Cerebral amyloid angiopathy-related leukodystrophy: a case report].
Topics: Aged, 80 and over; Cerebral Amyloid Angiopathy; Female; Humans; Leukoencephalopathies; Magnetic Resonance Imaging; Methylprednisolone; Prednisolone; Pulse Therapy, Drug; Treatment Outcome | 2012 |